https://www.selleckchem.com/pr....oducts/cytidine-5-tr
of reducing caregiver burden is recommended to integrate the patient, caregiver, and context characteristics in the trajectory of caregiver burden, and to assess more clearly the phase of the dementia progression and use of external resources. It is still unknown if serum glial fibrillary acidic protein (GFAP) is a useful marker in frontotemporal lobar degeneration (FTLD). To assess the diagnostic and prognostic value of serum GFAP in a large cohort of patients with FTLD. In this retrospective study, perfor
Like
Comment
Share
